Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data
- PMID: 35673849
- PMCID: PMC9288976
- DOI: 10.1002/sim.9427
Toward evaluation of disseminated effects of medications for opioid use disorder within provider-based clusters using routinely-collected health data
Abstract
Routinely-collected health data can be employed to emulate a target trial when randomized trial data are not available. Patients within provider-based clusters likely exert and share influence on each other's treatment preferences and subsequent health outcomes and this is known as dissemination or spillover. Extending a framework to replicate an idealized two-stage randomized trial using routinely-collected health data, an evaluation of disseminated effects within provider-based clusters is possible. In this article, we propose a novel application of causal inference methods for dissemination to retrospective cohort studies in administrative claims data and evaluate the impact of the normality of the random effects distribution for the cluster-level propensity score on estimation of the causal parameters. An extensive simulation study was conducted to study the robustness of the methods under different distributions of the random effects. We applied these methods to evaluate baseline prescription for medications for opioid use disorder among a cohort of patients diagnosed with opioid use disorder and adjust for baseline confounders using information obtained from an administrative claims database. We discuss future research directions in this setting to better address unmeasured confounding in the presence of disseminated effects.
Keywords: dissemination; health data; interference; medication for opioid use disorder; mixed effects models; opioid use disorder.
© 2022 John Wiley & Sons Ltd.
Figures


Similar articles
-
Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.Pain Physician. 2021 Mar;24(2):E249-E256. Pain Physician. 2021. PMID: 33740362 Free PMC article.
-
Accounting for confounding by time, early intervention adoption, and time-varying effect modification in the design and analysis of stepped-wedge designs: application to a proposed study design to reduce opioid-related mortality.BMC Med Res Methodol. 2021 Mar 16;21(1):53. doi: 10.1186/s12874-021-01229-6. BMC Med Res Methodol. 2021. PMID: 33726711 Free PMC article.
-
Inequities in access to primary care among opioid recipients in Ontario, Canada: A population-based cohort study.PLoS Med. 2021 Jun 1;18(6):e1003631. doi: 10.1371/journal.pmed.1003631. eCollection 2021 Jun. PLoS Med. 2021. PMID: 34061846 Free PMC article.
-
Causal Inference with Multilevel Data: A Comparison of Different Propensity Score Weighting Approaches.Multivariate Behav Res. 2022 Nov-Dec;57(6):916-939. doi: 10.1080/00273171.2021.1925521. Epub 2021 Jun 15. Multivariate Behav Res. 2022. PMID: 34128730 Review.
-
A systematic review of rural-specific barriers to medication treatment for opioid use disorder in the United States.Am J Drug Alcohol Abuse. 2020 May 3;46(3):273-288. doi: 10.1080/00952990.2019.1694536. Epub 2019 Dec 6. Am J Drug Alcohol Abuse. 2020. PMID: 31809217
Cited by
-
Assessing Spillover Effects of Medications for Opioid Use Disorder on HIV Risk Behaviors among a Network of People Who Inject Drugs.Stats (Basel). 2024 Jun;7(2):549-575. doi: 10.3390/stats7020034. Epub 2024 Jun 19. Stats (Basel). 2024. PMID: 40521388 Free PMC article.
References
-
- Chilcoat HD, Amick HR, Sherwood MR, Dunn KE. Buprenorphine in the United States: Motives for abuse, misuse, and diversion. Journal of Substance Abuse Treatment 2019; 104: 148–157. - PubMed
-
- Cooper HL, Cloud DH, Young AM, Freeman PR. When Prescribing Isn’t Enough-Pharmacy-Level Barriers to Buprenorphine Access. The New England Journal of Medicine 2020; 383(8): 703–705. - PubMed
-
- Friedman SR, Maslow C, Bolyard M, Sandoval M, Mateu-Gelabert P, Neaigus A. Urging others to be healthy:“Intravention” by injection drug users as a community prevention goal. AIDS Education and Prevention 2004; 16(3): 250–263. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical